SPL 1.03% 9.8¢ starpharma holdings limited

Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-98

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 9,392 Posts.
    lightbulb Created with Sketch. 874
    Yep i am aware of them. Nothing wrong with them and their strategy and it shows they are the smartest in the room

    The news examples. for big bucks are late stage etc

    What really amazes me is that they didn't pick up something SPL had in the lab that had already been advanced? With SPL current position it would have cost stuff all and saved time but they want to try a specific target.


 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.